KALARIS THERAPEUTICS, INC. (KLRS) Debt Components
- 2025-12-31: Convertible Notes Payable, CurrentUSD $0.00; Debt Instrument, Unamortized Discount, CurrentUSD (m).
- 2025-09-30: Convertible Notes Payable, CurrentUSD $0.00; Debt Instrument, Unamortized Discount, CurrentUSD (m).
- 2025-06-30: Convertible Notes Payable, CurrentUSD $0.00; Debt Instrument, Unamortized Discount, CurrentUSD (m).
- 2025-03-31: Convertible Notes Payable, CurrentUSD $0.00; Debt Instrument, Unamortized Discount, CurrentUSD (m).
KALARIS THERAPEUTICS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Debt Instrument, Unamortized Discount, Current USD |
|---|---|---|
| 2025-12-31 | $0.00 | (m) |
| 2025-09-30 | $0.00 | (m) |
| 2025-06-30 | $0.00 | (m) |
| 2025-03-31 | $0.00 | (m) |
| 2024-12-31 | $19.54M | $1.30M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |